tiprankstipranks
CytoDyn (CYDY)
OTHER OTC:CYDY

CytoDyn (CYDY) Stock Price & Analysis

613 Followers

CYDY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.15 - $0.42
Previous Close$0.17
Volume2.34M
Average Volume (3M)3.05M
Market Cap
$157.77M
Enterprise Value$197.26M
Total Cash (Recent Filing)$147.00K
Total Debt (Recent Filing)$33.13M
Price to Earnings (P/E)-2.7
Beta0.93
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding979,527,000
10 Day Avg. Volume1,272,673
30 Day Avg. Volume3,054,178
Standard Deviation0.49
R-Squared0.00049
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-1.44
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-16.40
P/FCF Ratio973.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-9.56
Enterprise Value/Ebitda-92.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

8.11%0.02%0.02%91.85%
8.11%
Insiders
0.02% Other Institutional Investors
91.85% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CYDY FAQ

What was CytoDyn’s price range in the past 12 months?
CytoDyn lowest stock price was $0.14 and its highest was $0.42 in the past 12 months.
    What is CytoDyn’s market cap?
    Currently, no data Available
    When is CytoDyn’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were CytoDyn’s earnings last quarter?
    Currently, no data Available
    Is CytoDyn overvalued?
    According to Wall Street analysts CytoDyn’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does CytoDyn pay dividends?
      CytoDyn does not currently pay dividends.
      What is CytoDyn’s EPS estimate?
      CytoDyn’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does CytoDyn have?
      CytoDyn has 986,058,400 shares outstanding.
        What happened to CytoDyn’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of CytoDyn?
        Currently, no hedge funds are holding shares in CYDY
        ---

        CytoDyn Stock Smart Score

        2
        Underperform
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -55.85%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        30.62%
        Trailing 12-Months

        Company Description

        CytoDyn

        CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Inovio Pharmaceuticals
        BioCryst
        AIM ImmunoTech
        Arcturus Therapeutics
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis